AI Engines For more Details: Perplexityβ Kagi Labsβ Youβ
Bacterial Infections: Josamycin is effective against a range of bacterial infections caused by susceptible organisms. It works by inhibiting bacterial protein synthesis, thereby preventing bacterial growth and replication.
Respiratory Tract Infections: Josamycin is commonly used to treat respiratory tract infections, including bronchitis, pneumonia, and pharyngitis caused by susceptible bacteria. It is particularly useful for respiratory infections in patients who are allergic to penicillin or have infections resistant to other antibiotics.
Skin and Soft Tissue Infections: Josamycin may be prescribed for the treatment of skin and soft tissue infections caused by susceptible bacteria, such as cellulitis, abscesses, and impetigo.
Sexually Transmitted Infections (STIs): Josamycin is sometimes used to treat sexually transmitted infections caused by susceptible organisms, such as chlamydia and ureaplasma urealyticum. It may be used as an alternative treatment in patients allergic to other antibiotics commonly used for STIs.
Acne: Josamycin has been used in the treatment of acne vulgaris, particularly in cases where other antibiotic therapies have failed or are contraindicated. It helps reduce the growth of acne-causing bacteria on the skin.
Prevention of Neonatal Group B Streptococcal Infection: In pregnant women colonized with group B streptococcus (GBS), josamycin may be used as prophylaxis to prevent transmission of the bacteria to the newborn during childbirth. It helps reduce the risk of neonatal GBS infection.
Pediatric Infections: Josamycin is available in formulations suitable for pediatric use, making it a suitable option for treating bacterial infections in children.
Pharmacokinetics: Josamycin is generally well-absorbed after oral administration, with good tissue penetration. It has a relatively long half-life, allowing for less frequent dosing compared to some other antibiotics.
Adverse Effects: Common side effects associated with josamycin include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. Allergic reactions and hypersensitivity reactions are possible but rare.
Drug Interactions: Josamycin may interact with other medications, particularly those metabolized by the liver or affecting cardiac conduction. It is important for healthcare providers to consider potential drug interactions when prescribing josamycin concurrently with other medications.
Resistance: As with other antibiotics, the emergence of bacterial resistance to josamycin is possible with prolonged or inappropriate use. Resistance monitoring and prudent antibiotic use are essential to mitigate the development of resistant bacterial strains.
Pregnancy and Lactation: Josamycin is generally considered safe for use during pregnancy and lactation when the benefits outweigh the risks. However, healthcare providers should weigh the potential risks and benefits before prescribing josamycin to pregnant or breastfeeding women.
(astellas josamycin, iosalide, josalid, josamycin, josamycin - guanghua pharm, josamycin - minsheng pharm, josamycin - sine, josamycin - suzhou no 1 pharm, wilprafen, wilprafen forte, beibeisha, cortifluoral, josacine, josalid kinder, josamina, josamy, josamy 10%, josamy 3%)
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Akkermansia muciniphila | Reduces |
species | Bacteroides uniformis | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium longum | Reduces |
species | Escherichia coli | Reduces |
species | Lacticaseibacillus paracasei | Reduces |
species | Parabacteroides distasonis | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
2 | 0 | Bacteroides fragilis | species | Decreases |
1 | 0 | Akkermansia | genus | Decreases |
1 | 0 | [Ruminococcus] torques | species | Decreases |
1 | 0 | Agathobacter rectalis | species | Decreases |
1 | 0 | Akkermansia muciniphila | species | Decreases |
1 | 0 | Bacteroides caccae | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
1 | 0 | Bacteroides uniformis | species | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
1 | 0 | Bifidobacterium adolescentis | species | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
1 | 0 | Bilophila wadsworthia | species | Decreases |
1 | 0 | Blautia obeum | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive β X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.9 | 0.9 | |
Acne | 1.1 | 0.9 | 0.22 |
ADHD | 5.6 | 0.6 | 8.33 |
Age-Related Macular Degeneration and Glaucoma | 1.1 | 0.4 | 1.75 |
Allergic Rhinitis (Hay Fever) | 3.9 | 3 | 0.3 |
Allergies | 8 | 5.1 | 0.57 |
Allergy to milk products | 2.1 | 1.6 | 0.31 |
Alopecia (Hair Loss) | 1.6 | 1.6 | |
Alzheimer's disease | 7.4 | 8.2 | -0.11 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 4.3 | 1 | 3.3 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. β Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA β Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. β Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. β Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.217 ]